131
Breast cancer array with adjacent normal breast tissue, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 110 cases/110 cores, replaced by BC081120c
(No reviews yet)
Write a Review
- SKU:
- 131-BC081120b-GEN
- Availability:
- IN STOCK
Description
Breast cancer array with adjacent normal breast tissue, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 110 cases/110 cores, replaced by BC081120c
Related Products
Breast cancer array with adjacent normal breast tissue, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/110 cores, replacing BC081120c
131
NULL399.00
Breast cancer array with adjacent normal breast tissue, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/110 cores, replacing BC081120c
131-BC081120d-GEN
Breast cancer tissue array with adjacent breast tissue as control,, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/ 110 cores, replacing BC081116a
131
NULL399.00
Breast cancer tissue array with adjacent breast tissue as control,, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/ 110 cores, replacing BC081116a
131-BC081116b-GEN
Breast cancer tissue array with adjacent normal breast tissue, including TNM, pathology grade, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced by BR1504c
131
NULL399.00
Breast cancer tissue array with adjacent normal breast tissue, including TNM, pathology grade, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced...
131-BR1504b-GEN
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM���clinical stage and IHC marker (ER, PR and Her-2), 189 cases/192 cores, replacing BR1921b
131
NULL602.00
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM���clinical stage and IHC marker (ER, PR and Her-2), 189 cases/192 cores, replacing BR1921b
131-BR1921c-GEN
Breast cancer with matched cancer adjacent breast tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki67), 40 cases/80 cores, replacing BR804a
131
NULL399.00
Breast cancer with matched cancer adjacent breast tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki67), 40 cases/80 cores, replacing BR804a
131-BR804b-GEN
Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replaced by BR1503e
131
NULL399.00
Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replaced by BR1503e
131-BR1503d-GEN
Breast cancer tissue array, including pathology grade, IHC markers (ER, PR, Her-2) results, 4 cases/8 cores, replaced by BR082c
131
NULL206.00
Breast cancer tissue array, including pathology grade, IHC markers (ER, PR, Her-2) results, 4 cases/8 cores, replaced by BR082c
131-BR082b-GEN
Breast cancer tissue array for antibody screening , including TNM, clinical stage, pathology grade, and IHC markers (ER, PR, Her-2) results, 50 cases/100 cores
131
NULL399.00
Breast cancer tissue array for antibody screening , including TNM, clinical stage, pathology grade, and IHC markers (ER, PR, Her-2) results, 50 cases/100 cores
131-BR1009-GEN
Breast disease spectrum (breast cancer progression) tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 192 cases/192 cores, replacing BR2082a
131
NULL602.00
Breast disease spectrum (breast cancer progression) tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 192 cases/192 cores, replacing BR2082a
131-BR2082b-GEN